Li-Fraumeni syndrome: the genetics and treatment considerations for the sarcoma and associated neoplasms.

Abstract excerpt

Li-Fraumeni syndrome is an autosomal dominant disorder first reported by Drs Li and Fraumeni in 1969. Malkin was the first to describe a germline mutation as an underlying defect of Li-Fraumeni syndrome. Cancer risk in mutation carriers has been estimated to be 50% by age 40 and 90% by age 60. Children of affected parents have an approximate 50% risk of inheriting the familial mutation. Functional assays have...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Checkpoint Kinase 1
• Share to Checkpoint Kinase 2
• Share to Germ-Line Mutation